A meta-analysis comparing regorafenib with TAS-102 for treating refractory metastatic colorectal cancer

OBJECTIVE: We performed this meta-analysis to compare the efficacy and toxicity of regorafenib and TAS-102. METHODS: Electronic databases were searched to identify studies comparing the efficacy and safety of regorafenib and TAS-102 in patients with chemotherapy-refractory metastatic colorectal canc...

पूर्ण विवरण

में बचाया:
ग्रंथसूची विवरण
में प्रकाशित:J Int Med Res
मुख्य लेखकों: Su, Guan-Li, Wang, Yuan-Yuan, Wang, Jin-Cheng, Liu, Hao
स्वरूप: Artigo
भाषा:Inglês
प्रकाशित: SAGE Publications 2020
विषय:
Meta-Analysis
ऑनलाइन पहुंच:https://ncbi.nlm.nih.gov/pmc/articles/PMC7361493/
https://ncbi.nlm.nih.gov/pubmed/32660291
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/0300060520926408
टैग : टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!

समान संसाधन